Table 3.
Association of clinical variables with past-month drinking, NSDUH, 2002–2017
Pregnant women n=13,488 |
Does association differ by pregnancy stage?a | Early pregnancy n=4,104 |
Middle/late pregnancy n=9,384 |
||||
---|---|---|---|---|---|---|---|
Prevalence of drinking among the subgroup %b (SE) |
Odds ratiob (95% CI) |
Wald F(df), p-value |
Prevalence of drinking among the subgroup %c (SE) |
Odds ratioc (95% CI) |
Prevalence of drinking among the subgroup %c (SE) |
Odds ratioc (95% CI) |
|
Trimester | |||||||
First | 19.1 (0.92) | Reference | |||||
Second | 6.5 (0.55) | 0.29 (0.23, 0.36) | |||||
Third | 4.6 (0.56) | 0.20 (0.15, 0.27) | |||||
Past year disorder | |||||||
Alcohol use disorder | 0.88(1), p=0.35 | ||||||
Yes | 27.0 (2.05) | 4.46 (3.43, 5.81) | |||||
No | 8.6 (0.42) | Reference | |||||
Depressiond | 0.04(1), p=0.84 | ||||||
Yes | 13.6 (1.79) | 1.58 (1.12, 2.24) | |||||
No | 9.4 (0.79) | Reference | |||||
Past month substance use | |||||||
Tobacco | 0.37(1), p=0.54 | ||||||
Yes | 18.8 (1.29) | 2.85 (2.33, 3.49) | |||||
No | 8.1 (0.43) | Reference | |||||
Marijuana | 4.50(1), p=0.035 | ||||||
Yes | 35.7 (2.64) | 7.13 (5.42, 9.39) | 50.3 (4.28) | 5.29 (3.70, 7.57) | 34.8 (4.47) | 11.45 (7.37, 17.78) | |
No | 8.5 (0.42) | Reference | 17.0 (0.88) | Reference | 4.8 (0.40) | Reference | |
Cocaine | 0.45(1), p=0.50 | ||||||
Yes | 51.9 (11.12) | 13.41 (4.91, 36.63) | |||||
No | 9.7 (0.41) | Reference | |||||
Any druge | 3.27(1), p=0.07 | ||||||
Yes | 34.3 (2.87) | 6.63 (4.85, 9.06) | |||||
No | 8.6 (0.49) | Reference |
Differential association was indicated by significant interaction between the risk factor and pregnancy stage in logistic regression. Where interaction was significant (p<0.05), results are shown stratified by pregnancy stage.
Adjusted for age, race/ethnicity, education, income, marital status, trimester, and year.
Adjusted for all except trimester.
For depression, n=10,787, because this variable was not available for 2002–2004.
Use of marijuana, cocaine, heroin, hallucinogens, methamphetamine, inhalants, or non-medical use of prescription psychotherapeutics (opioid pain relievers, stimulants, sedatives, or tranquilizers); n=11,262, available 2002–2014.